BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,601,317 | -19.5% | 280,904 | -2.8% | 0.03% | -10.0% |
| Q2 2023 | $13,162,785 | -17.9% | 288,911 | -26.9% | 0.03% | -23.1% |
| Q1 2023 | $16,039,371 | -19.2% | 395,448 | +1.6% | 0.04% | -25.0% |
| Q4 2022 | $19,845,628 | +6.9% | 389,359 | +12.9% | 0.05% | 0.0% |
| Q3 2022 | $18,572,000 | -23.8% | 344,808 | -9.1% | 0.05% | -16.1% |
| Q2 2022 | $24,371,000 | -10.3% | 379,432 | +8.3% | 0.06% | 0.0% |
| Q1 2022 | $27,170,000 | -13.8% | 350,402 | -4.5% | 0.06% | -4.6% |
| Q4 2021 | $31,505,000 | +5.5% | 367,025 | -1.1% | 0.06% | 0.0% |
| Q3 2021 | $29,858,000 | +0.8% | 371,238 | +0.9% | 0.06% | +3.2% |
| Q2 2021 | $29,624,000 | -11.8% | 368,010 | -8.0% | 0.06% | -14.9% |
| Q1 2021 | $33,579,000 | -14.5% | 399,871 | -18.3% | 0.07% | -6.3% |
| Q4 2020 | $39,253,000 | -1.3% | 489,201 | -1.1% | 0.08% | -12.2% |
| Q3 2020 | $39,762,000 | -9.1% | 494,441 | -2.6% | 0.09% | -15.1% |
| Q2 2020 | $43,723,000 | +4.1% | 507,828 | -1.8% | 0.11% | -13.1% |
| Q1 2020 | $41,999,000 | +0.3% | 517,295 | +3.3% | 0.12% | +22.0% |
| Q4 2019 | $41,866,000 | -9.7% | 500,678 | -7.1% | 0.10% | -16.0% |
| Q3 2019 | $46,381,000 | +11.6% | 538,838 | +5.9% | 0.12% | -16.2% |
| Q2 2019 | $41,559,000 | +14.4% | 508,864 | +11.7% | 0.14% | +6.0% |
| Q1 2019 | $36,318,000 | +9.8% | 455,739 | -9.3% | 0.13% | -2.9% |
| Q4 2018 | $33,076,000 | -14.6% | 502,517 | +0.0% | 0.14% | 0.0% |
| Q3 2018 | $38,725,000 | -54.5% | 502,339 | -56.4% | 0.14% | -4.8% |
| Q2 2018 | $85,115,000 | +7.9% | 1,152,697 | -5.0% | 0.14% | +4.3% |
| Q1 2018 | $78,891,000 | +1.2% | 1,212,957 | +0.6% | 0.14% | +2.2% |
| Q4 2017 | $77,951,000 | +12.1% | 1,205,929 | +8.8% | 0.14% | +5.4% |
| Q3 2017 | $69,536,000 | +4.8% | 1,108,138 | +1.1% | 0.13% | +0.8% |
| Q2 2017 | $66,334,000 | +14.5% | 1,095,707 | -1.9% | 0.13% | +11.3% |
| Q1 2017 | $57,931,000 | +9.8% | 1,117,070 | -6.1% | 0.12% | +3.6% |
| Q4 2016 | $52,746,000 | -18.0% | 1,189,570 | -12.0% | 0.11% | -16.5% |
| Q3 2016 | $64,345,000 | +3.1% | 1,351,794 | -2.1% | 0.13% | -2.9% |
| Q2 2016 | $62,433,000 | +32.6% | 1,380,651 | +20.5% | 0.14% | +29.2% |
| Q1 2016 | $47,083,000 | +9.9% | 1,146,126 | +2.0% | 0.11% | +8.2% |
| Q4 2015 | $42,852,000 | +10.5% | 1,123,255 | -4.9% | 0.10% | +3.2% |
| Q3 2015 | $38,784,000 | -59.1% | 1,180,635 | -12.9% | 0.10% | -56.2% |
| Q2 2015 | $94,744,000 | +17.9% | 1,354,845 | +15.5% | 0.22% | +16.7% |
| Q1 2015 | $80,364,000 | -1.0% | 1,173,194 | +5.9% | 0.19% | -3.1% |
| Q4 2014 | $81,161,000 | -20.0% | 1,107,402 | -21.7% | 0.19% | -22.3% |
| Q3 2014 | $101,449,000 | -18.8% | 1,413,525 | -18.2% | 0.25% | -14.2% |
| Q2 2014 | $124,939,000 | -0.6% | 1,728,063 | +1.1% | 0.29% | -5.6% |
| Q1 2014 | $125,743,000 | +8.8% | 1,708,930 | +2.8% | 0.30% | +7.0% |
| Q4 2013 | $115,604,000 | +5.8% | 1,662,171 | -0.1% | 0.28% | -2.1% |
| Q3 2013 | $109,306,000 | +0.6% | 1,663,966 | +6.1% | 0.29% | -4.9% |
| Q2 2013 | $108,635,000 | – | 1,568,279 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |